Cover Image

Regulatory exclusivity reform in the 115th Congress /

Bibliographic Details
Main Author:	Thomas, John R., 1967- (Author)
Format:	Government Document Database
Language:	English
Published:	[Washington, D.C.] : Congressional Research Service, 2019-
Edition:	[Library of Congress public edition].
Series:	CRS report ; R44951.
Subjects:	United States. > Food and Drug Administration. Pharmaceutical policy > United States. Drugs > Law and legislation > United States.
Online Access:	https://purl.fdlp.gov/GPO/gpo125341

Similar Items

FDA in the twenty-first century : the challenges of regulating drugs and new technologies /
Published: (2015)

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)

Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling.
Published: (2014)

Biosimilar Implementation : A Progress Report from FDA.
Published: (2015)

Patents and regulatory exclusivities : issues in pharmaceutical innovation and competition /
by: Thomas, John R.
Published: (2018)

How FDA approves drugs and regulates their safety and effectiveness /
by: Dabrowska, Agata
Published: (2018)

From test tube to patient : protecting America's health through human drugs.
Published: (2006)

Examining FDA's Prescription Drug User Fee Program.
Published: (2017)

Drug Regulation Reform Act of 1978 : the administration proposal : section-by-section analysis, H.R. 11611 and S. 2755, 95th Congress, second session.
Published: (1978)

Discussion draft of the Food and Drug Administration Globalization Act legislation : drug safety : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 1, 2008.
Published: (2008)

FDA Amendments Act of 2007 (P.L. 110-85) /
by: Thaul, Susan
Published: (2018)

Improving Predictability and Transparency in DEA and FDA Regulations.
Published: (2014)

The Proposed Drug Quality and Security Act (H.R. 3204) /
by: Thaul, Susan
Published: (2020)

Reforming the Drug Compounding Regulatory Framework.
Published: (2013)

The Heparin disaster : Chinese counterfeits and American failures : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 29, 2008.
Published: (2008)

FDA warning letters : trends and perspectives.
Published: (1999)

FDA warning letters : timeliness and effectiveness.
Published: (1999)

Regulation of over-the-counter (OTC) drugs /
by: Dabrowska, Agata
Published: (2018)

Perspectives of drug manufacturers : investigational new drug and new drug applications.
Published: (1990)

Generic drug utilization in state Medicaid programs.
Published: (2006)

Monitoring Medicare Part B drug prices : a comparison of average sales prices to average manufacturer prices.
Published: (2006)

Generic drug utilization in the Medicare Part D program.
Published: (2007)

Reviewing FDA's Implementation of FDASIA.
Published: (2013)

Medicare payments for newly available generic drugs.
Published: (2011)

Perspectives of drug manufacturers : abbreviated new drug applications.
Published: (1990)

60 minutes.
Published: (2005)

FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development /
by: Dabrowska, Agata
Published: (2018)

Heroin trafficking in the United States /
by: Finklea, Kristin M.
Published: (2018)

State Medicaid policies and oversight activities related to 340B-purchased drugs.
Published: (2011)

60 minutes.
Published: (2005)

Guidebook for drug regulatory submissions /
by: Weinberg, Sandy, 1950-
Published: (2009)

Inappropriate Medicare Part D payments for Schedule II drugs billed as refills.
Published: (2012)

Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages.
Published: (2012)

Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain.
Published: (2017)

The impact of high-priced generic drugs on Medicare and Medicaid.
Published: (1998)

Prescription Drug User Fee Act (PDUFA) : 2017 reauthorization as PDUFA VI /
by: Dabrowska, Agata, et al.
Published: (2018)

Prescription Drug User Fee Act (PDUFA) : 2012 reauthorization as PDUFA V /
by: Thaul, Susan
Published: (2019)

Medicaid brand-name drugs : rising prices are offset by manufacturer rebates.
Published: (2011)

Prescription Drug Shortages : Examining a Public Health Concern and Potential Solutions.
Published: (2011)

Examining Drug Shortages and Recent Efforts To Address Them.
Published: (2014)